Infertility References

  1. MedWormhttp://www.medworm.com/rss/index.php/Endocrinology/15/http://www.medworm.com/rss/medicalfeeds/specialities/Endocrinology.xml
  2. MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
  3. Loh SF, Agarwal R, Chan J, et al. Academy of Medicine-Ministry of Health clinical practice guidelines: assessment and management of infertility at primary healthcare level. Singapore Med J. 2014 Feb;55(2):58-65. http://www.sma.org.sg. PMID: 24570313
  4. Kuohung W, Hornstein MD. Overview of treatment of female infertility. UpToDate. http://www.uptodate.com. 17 Apr 2015. Accessed 27 Apr 2015.
  5. Subramaniam R, Sinthamoney E, Damodaran P, et al. Clinical guidelines for the management of endometriosis 2016. Obstetrical and Gynaecological Society of Malaysia (OGSM). http://www.ogsm.org.my. 2016. Accessed 24 Jan 2017.
  6. World Health Organization (WHO). Global prevalence of infertility, infecundity and childlessness. WHO. http://www.who.int/. 2017. Accessed 02 Mar 2017.
  7. Wang R, Kim BV, van Wely M, et al. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ. 2017 Jan 31;356:j138. doi: 10.1136/bmj.j138. Accessed 02 May 2017. PMID: 28143834
  8. Fauser BCJM. Overview of ovulation induction. UpToDate. https://www.uptodate.com. 20 Nov 2024. Accessed 21 Feb 2022.
  9. Snyder PJ. Causes of hyperprolactinemia. UpToDate. https://www.uptodate.com. Mar 2017. Accessed 6 Sep 2017.
  10. Snyder PJ. Patient education: high prolactin levels and prolactinomas. UpToDate. https://www.uptodate.com. Jul 2017. Accessed 6 Sep 2017.
  11. Practice Committee of the American Society for Reproductive Medicine. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018 Jun;109(6):993-999. doi: 10.1016/j.fertnstert.2018.03.019. Accessed 02 Aug 2018. PMID: 29935660
  12. Practice Committee of the American Society for Reproductive Medicine. The role of immunotherapy in in vitro fertilization: a guideline. Fertil Steril. 2018 Aug;110(3):387-400. doi: 10.1016/j.fertnstert.2018.05.009. Accessed 23 May 2019. PMID: 30098685
  13. Barbieri RL, Ehrmann DA. Treatment of polycystic ovary syndrome in adults. UpToDate. https://www.uptodate.com. 10 May 2022. Accessed 02 Oct 2023.
  14. American College of Obstetricians and Gynecologists’ Committee of Gynecologic Practice, American Society for Reproductive Medicine. Infertility workup for the women’s health specialist: ACOG Committee opinion, number 781. Obstet Gynecol. 2019 Jun;133(6):e377-e384. doi: 0.1097/AOG.0000000000003271. Accessed 10 May 2021. PMID: 31135764
  15. Buckett W, Sierra S. The management of unexplained infertility: an evidence-based guideline from the Canadian Fertility and Andrology Society. Reprod Biomed Online. 2019 Oct;39(4):633-640. doi: 10.1016/j.rbmo.2019.05.023. Accessed 10 May 2021. PMID: 31439397
  16. Costello MF, Misso ML, Balen A, et al. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Hum Reprod Open. 2019 Jan;2019(1):hoy021. doi: 10.1093/hropen/hoy021. Accessed 10 May 2021. PMID: 31486807
  17. Hornstein MD, Gibbons WE. Unexplained infertility. UpToDate. https://www.uptodate.com. 12 Apr 2020. Accessed 10 May 2021.
  18. Hunt S, Vollenhoven B. Assessment of female fertility in the general practice setting. Aust J Gen Pract. 2020 Jun;49(6):304-308. doi: 10.31128/AJGP-01-20-5205. Accessed 10 May 2021. PMID: 32464730
  19. Myers ER, Eeaton JL, McElligot KA, et al. Management of infertility. Comparative effectiveness review no. 217. Rockville, MD: Agency for Healthcare Research and Quality. May 2019. doi: https://www.effectivehealthcare.ahrq.gov. Accessed 10 May 2021
  20. Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020 Feb;113(2):305-322. doi: 10.1016/j.fertnstert.2019.10.014. Accessed 10 May 2021. PMID: 32106976
  21. Practice Committee of the American Society for Reproductive Medicine. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril. 2021 May;115(5):1143-1150. doi: 10.1016/j.fertnstert.2021.01.051. Accessed 10 May 2021. PMID: 33642065
  22. The ESHRE Guideline Group on Reproductive Endocrinology; Bosch E, Broer S, Griesinger G, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020 May;2020(2):hoaa009. doi: 10.1093/hropen/hoaa009. Accessed 10 May 2021. PMID: 32395637
  23. Toth B, Baston-Büst DM, Behre HM, et al. Diagnosis and therapy before assisted reproductive treatments. Guideline of the DGGG, OEGGG and SGGG (S2K level, AWMF register number 015-085, February 2019) – part I, basic assessment of the woman. Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1278-1292. doi: 10.1055/a-1017-3389. Accessed 10 May 2021. PMID: 31875858
  24. Kunev AK. Diagnostics and treatment of cervical causes of infertility. J Biomed Clin Res. 2019 Dec;12(1):33-39. doi: 10.2478/jbcr-2019-0005. Accessed 24 May 2021
  25. Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016 Nov;22(6):687-708. doi: 10.1093/humupd/dmw025. Accessed 21 Feb 2022. PMID: 27511809
  26. Drakopoulos P, Bardhi E, Boudry L, et al. Update on the management of poor ovarian response in IVF: the shift from Bolonga criteria to the Poseidon concept. Ther Adv Reprod Health. 2020 Jul;14:2633494120941480. doi: 10.1177/2633494120941480. PMID: 32844159
  27. Ferraretti AP, Marca AL, Fauser BJCM, et al. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011 Jul;26(7):1616-1624. doi: 10.1093/humrep/der092. Accessed 24 Feb 2022. PMID: 21505041
  28. Haakman O, Liang T, Murray K, et al. In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta. F S Rep. 2020 Dec;2(1):30-35. doi: 10.1016/j.xfre.2020.12.002. PMID: 34223270
  29. Hornstein MD, Gibbons WE. Endometriosis: treatment of infertility in females. UpToDate. https://www.uptodate.com. 20 Sep 2021.
  30. Jungwirth A, Diemer T, Kopa Z, et al. EAU guidelines on male infertility. European Association of Urology (EAU). https://uroweb.org/. Mar 2018. Accessed 21 Feb 2022.
  31. Kakarla N, Bradshaw KD. Evaluation and management of the infertile couple. Glob Libr Women’s Med. 2008. doi: 10.3843/ GLOWM.10321.
  32. Koechling W, Plasin D, Croston GE, et al. Comparative pharmacology of a new recombinant FSH expressed by a human cell line. Endocr Connect. 2017 Jul;6(5):297-305. doi: 10.1530/ EC-17-0067. Accessed 21 Feb 2021. PMID: 28450423
  33. Kuohung W, Hornstein MD. Evaluation of female infertility. UpToDate. https://www.uptodate.com. 08 Mar 2021.
  34. Morris ME. Evaluation and management of infertility in females of advancing age. UpToDate. https://www.uptodate.com. 18 Feb 2022.
  35. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012 Sep;98(3):591-598. doi: 10.1016/j. fertnstert.2012.05.031. PMID: 22704630
  36. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021 Nov;116(5):1255-1265. doi: 10.1016/j.fertnstert.2021.08.038. PMID: 34607703
  37. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measure of ovarian reserve: a committee opinion. Fertil Steril. 2015 Mar;103(3):e9-e17. doi: 10.1016/j.fertnstert.2014.12.093. Accessed 24 Feb 2022. PMID: 25585505
  38. Practice Committee of the American Society for Reproductive Medicine. Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion. Fertil Steril. 2020 Jan;113(1):66-70. doi: 10.1016/j. fertnstert.2019.09.020. PMID: 32033726
  39. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. J Urol. 2021 Jan;205(1):36-43. doi: 10.1097/JU.0000000000001521. Accessed 21 Feb 2022. PMID: 33295257
  40. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II. J Urol. 2021 Jan;205(1):44-51. doi: 10.1097/JU.0000000000001520. PMID: 33295258
  41. Christ JP, Cedars MI. Current guidelines for diagnosing PCOS. Diagnostics (Basel). 2023 Mar;13(6):1113. doi: 10.3390/diagnostics13061113. Accessed 27 Sep 2023. PMID: 36980421
  42. Romualdi D, Ata B, Bhattacharya S, et al. Evidence-based guideline: unexplained infertility. 2023. Hum Reprod. 2023 Oct;38(10):1881-1890. doi: 10.1093/humrep/dead150. PMID: 37599566
  43. Teede HJ, Tay CT, Laven J, et al on behalf of the International PCOS Network. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023 Sep;108(10):2447-2469. doi: 10.1210/clinem/dgad463. Accessed 27 Sep 2023. PMID: 37580314
  44. Balen AH, Tamblyn J, Skorupskaite K, et al. A comprehensive review of the new FIGO classification of ovulatory disorders. Human Reprod Update. 2024 May;30(3):355-382. doi: 10.1093/humupd/dmae003. Accessed 01 Aug 2025. PMID: 38412452
  45. Bolton VN, Perez MJ, Hughes G, et al. The use of ICSI in ART: evidence of practice. Hum Fertil (Camb). 2023 Jul;26(3):414-432. doi: 10.1080/14647273.2023.2243071. Accessed 01 Aug 2025. PMID: 37609991
  46. ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI, Panay N, Anderson AA, Bennie A, et al. Evidence-based guideline: premature ovarian insufficiency. Climacteric. 2024 Dec;27(6):510-520. doi: 10.1080/13697137.2024.2423213. PMID: 39647506
  47. The guideline development group on premature ovarian insufficiency European Society of Human Reproduction and Embryology (ESHRE). Premature ovarian insufficiency (POI). ESHRE. https://www.eshre.eu/. 2024.
  48. Kuohung W, Hornstein MD. Female infertility: causes. UpToDate. https://www.uptodate.com. 01 May 2025.
  49. Kuohung W, Hornstein MD. Overview of infertility. UpToDate. https://www.uptodate.com. 18 Oct 2023.
  50. Legro RS. The new International Federation of Gynecology and Obstetrics (FIGO) classification of ovulatory disorders: getting from here to there. Fertil Steril. 2023 Apr;119(4):560-561. doi: 10.1016/j.fertnstert.2023.01.049. PMID: 36764439
  51. Munro MG, Balen AH, Cho S, et al. The FIGO ovulatory disorders classification system. Int J Gynaecol Obstet. 2022 Oct;159(1):1-20. doi: 10.1002/ijgo.14331. PMID: 35983674
  52. Phillips K, Olanrewaju RA, Omole F. Infertility: evaluation and management. Am Fam Physician. 2023 Jun;107(6):623-630. doi: https://www.aafp.org. PMID: 37327165
  53. Skorupskaite K, Hardy M, Bhandari H, et al. Evidence based management of patients with endometriosis undergoing assisted conception: British Fertility Society policy and practice recommendations. Hum Fertil (Camb). 2024 Dec;27(1):2288634. doi: 10.1080/14647273.2023.2288634. PMID: 38226584
  54. World Health Organization (WHO). Infertility. WHO. https://www.who.int/. 2024.
  55. Cox CM, Thoma ME, Tchangalova N, et al. Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis. Hum Reprod Open. 2022 Nov;2022(4):hoac051. doi: 10.1093/hropen/hoac051. PMID: 36483694
  56. Obeagu EI, Njar VE, Obeagu GU. Infertility: prevalence and consequence. Int J Curr Res Chem Pharm Sci. 2023;10(7):43-50. doi: 10.22192/ijcrcps. Accessed 02 Sep 2025
  57. Kuohung W, Hornstein MD. Female infertility: treatments. UpToDate. https://www.uptodate.com. 19 Jun 2025.
  58. National Institute for Health and Care Excellence (NICE). Fertility problems: assessment and treatment. NICE. https//www.nice.org.uk/. 31 Mar 2026.
  59. World Health Organization (WHO). Guideline for the prevention, diagnosis and treatment of infertility. WHO. https//www.who.int/. 2025.
  60. Teede HJ, Khomami MB, Morman R, et al, on behalf of the Global Name Change Consortium. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026 May 12. https://doi.org/10.1016/S0140-6736(26)00717-8. Accessed 13 May 2026